Jensen Huang Sets the Record Straight
NVIDIA CEO Jensen Huang Debunks WSJ Rumors, Reaffirms Strong Partnership with OpenAI
In a bold statement, NVIDIA CEO Jensen Huang has dismissed recent rumors of dissatisfaction with OpenAI, emphasizing NVIDIA's unwavering commitment to a substantial investment in the AI powerhouse. Speaking from Taipei, Huang refuted claims of internal doubts at NVIDIA and reiterated the company's plans to participate in OpenAI's current financing round, while clarifying that investments will not exceed the previously announced $100 billion cap. This solidifies NVIDIA's role in supporting OpenAI's operations and chip supply needs, bolstering investor confidence in NVIDIA's AI dominance.
Introduction: Unraveling the News
Denial of Media Claims by NVIDIA
Jensen Huang's Speech in Taipei
Details of the USD100 Billion Investment
NVIDIA's Partnership with OpenAI
Response to Wall Street Journal Reports
Market Implications for NVIDIA Stocks
Jensen Huang's Relationship with Sam Altman
Impact on the AI Market
OpenAI's Current Financing Round
Timeline and Expectations of the Deal
Recent Developments in NVIDIA‑OpenAI Collaboration
Economic Implications of the Investment
Social Consequences of AI Advancements
Political and Regulatory Considerations
Related News
Apr 24, 2026
DeepSeek's Open-Source A.I. Surge: Game Changer in Global Competition
DeepSeek's release of its open-source V4 model propels its position in the A.I. race, challenging American giants with cost-efficiency and openness. For global builders, this marks a new era of accessible, powerful tools for software development.
Apr 24, 2026
White House Hits Back at China's Alleged AI Tech Theft
A White House memo has accused Chinese firms of large-scale AI technology theft. Michael Kratsios warns of systematic tactics undermining US R&D. No specific punitive measures detailed yet.
Apr 24, 2026
OpenAI Debuts ChatGPT for Clinicians with Free CME Credits and Cited Medical Insights
OpenAI rolls out ChatGPT for Clinicians, offering U.S. healthcare providers a free tool to access cited medical sources and earn CME credits. Built on GPT-5.4, this tool aids doctors, nurse practitioners, and other licensed clinicians in streamlining research and clinical documentation. The platform emphasizes professional support without replacing clinical judgment.